R. Hirschmann

MAXIS is a medical device development company, focused on maximizing the clinical and commercial success of emerging medical device technologies. MAXIS’ ability to create customized strategies and all phases of clinical trials, paired with its commitment to providing comprehensive, long-term support, make us uniquely suited to start-up clients. In-source an exceptional senior team with comprehensive, multidisciplinary backgrounds and experience, that cannot be hired in one individual. The team’s experience in preclinical engineering, regulatory affairs, clinical research and market development, provide unmatched, results-driven strategic and operational expertise, leading to the increased valuation and success of start-up companies. MAXIS provides comprehensive, long-term support, making us particularly suited to start-up clients. The MAXIS methodology creates credible funding milestones that ‘engineer the market’ for success and ensure that commercial value is grounded in solid science.